PGR and Gynecomastia: Its unique dibenzothiophene-based structure confers high selectivity for MR while exhibiting negligible affinity for androgen or progesterone receptors, thereby minimizing endocrine-related adverse effects like gynecomastia and menstrual irregularities observed with Spironolactone [25].